Is obinutuzumab considered immunotherapy?

Publish date: 2022-12-04

Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving bendamustine, obinutuzumab, and venetoclax may work better in treating patients with mantle cell lymphoma.

Is obinutuzumab chemotherapy or immunotherapy?

Obinutuzumab is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. Obinutuzumab is classified as a "monoclonal antibody" (For more detail, see "How Obinutuzumab Works" section below).

What kind of drug is obinutuzumab?

Obinutuzumab is a type of targeted cancer drug called a monoclonal antibody. Monoclonal antibodies work by recognising and finding specific proteins on cells. Obinutuzumab targets a protein called CD20 on the surface of the lymphoma and leukaemia cells.

What is the difference between obinutuzumab and rituximab?

Obinutuzumab is a type II antibody, unlike rituximab, which is a type I antibody. These classifications are based on the way the antibodies bind to CD20.

Is obinutuzumab an immunosuppressant?

Use Caution/Monitor. Immunization with live virus vaccines is not recommended during obinutuzumab treatment and until after B-cell recovery. siponimod and obinutuzumab both increase immunosuppressive effects; risk of infection. Use Caution/Monitor.

32 related questions found

What is the half life of Obinutuzumab?

Obinutuzumab has a volume of distribution of approximately 3.8 L, a total body clearance of 0.09 L/day, and an elimination half-life of approximately 28.4 days.

What are the side effects of Obinutuzumab?

Side Effects

Is obinutuzumab toxic?

Our systematic review and meta-analysis demonstrates that obinutuzumab has a more severe toxicity profile as compared to rituximab.

Does Venclexta cause weight gain?

Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.

Is there an alternative to rituximab?

Ofatumumab is a feasible alternative anti-CD20 therapy in patients intolerant of rituximab.

Does obinutuzumab cause weight gain?

Your doctor may give you a medicine to help prevent this. Call your doctor right away if you have a decrease or change in urine amount, joint pain, stiffness, or swelling, lower back, side, or stomach pain, a rapid weight gain, swelling of the feet or lower legs, or unusual tiredness or weakness.

Does obinutuzumab cause shortness of breath?

Swelling of your face, lips, tongue or throat with difficulty breathing; Swelling of other parts of your body; Shortness of breath, wheezing or trouble breathing; Skin problems including rash, itchiness or hives, hardened or discoloured skin lesions which may increase in size.

Can I drink alcohol while taking obinutuzumab?

The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of obinutuzumab. pregnancy. It is best to use birth control while being treated with obinutuzumab and for 18 months after your last dose of obinutuzumab.

Can obinutuzumab cause pneumonitis?

Cases that did occur were effectively treated with steroids, and there were no fatalities associated with pneumonitis. Ofatumumab and obinutuzumab were not associated with any cases of interstitial pneumonitis.

How long is obinutuzumab infusion?

Administer at 25 mg/hr over 4 hours. Do not increase the infusion rate.

How often is obinutuzumab given?

GAZYVA is given for a total of 6 cycles, or rounds of treatment. Each cycle will last 28 days. Treatment occurs only on certain days of each cycle and that is usually followed by several weeks of rest and recovery. This means that most people will complete their GAZYVA treatment in about 6 months.

Is Venclexta an immunotherapy?

Venetoclax may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell growth. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread.

Is CLL the same as multiple myeloma?

CLL and multiple myeloma are two types of blood cancer. CLL causes your body to produce too many abnormal B cells that crowd out healthy blood cells. Multiple myeloma develops in plasma cells, which are a type of B cell that produce antibodies.

Is venetoclax considered chemotherapy?

Technically, Venclexta (venetoclax) is a type of targeted treatment rather than chemotherapy. Chemotherapy is defined as a drug treatment that kills fast-growing cells in your body, which means that it often kills other normal cells in your body that are fast-growing, such as red blood cells and cells in your hair.

When was Obinutuzumab approved?

On November 16, 2017, the Food and Drug Administration granted regular approval to obinutuzumab (GAZYVA, Genentech, Inc.)

What cells express CD20?

CD20 is a cell surface tetraspan receptor expressed exclusively on B-lymphocytes. The absence of this receptor in bone marrow cells but presence in lymphoma cells makes it an attractive target for cancer chemotherapy (Cirstoiu-Hapca et al., 2007).

Is chlorambucil a chemotherapy?

Chlorambucil is a chemotherapy drug and is also known by its brand name Leukeran. It is used mainly to treat: chronic lymphocytic leukaemia (CLL) Non-Hodgkin lymphoma.

Is Obinutuzumab a monoclonal antibody?

Data synthesis: Obinutuzumab is a novel glycoengineered type II anti-CD20 monoclonal antibody, with a higher affinity for CD20 epitope, leading to superior cytotoxicity compared with rituximab.

What is Obinutuzumab used for?

GAZYVA® (obinutuzumab) is a prescription medicine used with the chemotherapy drug, chlorambucil, to treat chronic lymphocytic leukemia (CLL) in adults who have not had previous CLL treatment.

What are the side effects of Acalabrutinib?

Side Effects

ncG1vNJzZmiZnKG8tsDFqKatmpGhuW%2BvzmespGeWlr5wtdJmppuhnqrBtsbUppibZZOku7S1w56pnpxdnrquwc2oq6Gdopa9ug%3D%3D